跳至主要内容
临床试验/2023-509109-57-01
2023-509109-57-01招募中4 期

Hip Infiltration in Hip Arthroplasty (HiHa) study – a randomized controlled trial

Reinier Haga Groep Orthopedisch Centrum B.V.1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年4月24日最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
120
试验地点
1
主要终点
Use of escape pain medication during the first 6 hours after the intra-articular injection of the hip

研究概览

简要总结

The main objective is to determine if preoperative intra-articular infiltration (IAI) of the hip joint with Ropivacaine and Adrenaline reduces the number of patients needing postoperative escape pain medication after total hip arthroplasty, compared to a placebo AIA of the hip joint.

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Age > 18 years
  • On the waiting list for primary THA via the ASI by one of participating orthopaedic surgeons
  • ASA 1, ASA 2 or ASA 3
  • Eligible to receive the full enhanced recovery pain- and anesthetic protocol
  • Willing to participate
  • Willing to provide written informed consent

排除标准

  • Decline to participate
  • Participants will be excluded postoperatively if the duration of surgery exceeds 90 minutes
  • Unable to effectively communicate in Dutch or English
  • Use of opioids preoperatively
  • Use of NSAID’s for an indication other than the hip for which surgery is planned
  • Allergy or contraindication for the contents (Ropivacaine or adrenaline) of the preoperative infiltration
  • Allergy or contraindication for medication used in the standardized postoperative pain protocol
  • Allergy or contraindication for medication used in the standardized anaesthetic protocol
  • Allergy or contraindication for the standardized escape medication

结局指标

主要结局

Use of escape pain medication during the first 6 hours after the intra-articular injection of the hip

Use of escape pain medication during the first 6 hours after the intra-articular injection of the hip

次要结局

  • Percentage of patients that use escape pain medication on day 0 and during hospital stay until discharge
  • Pain measured with NRS
  • Side effects related to the use of pain medication
  • Amount of other escape medication used
  • Satisfaction measured with the Net Promotor Score (NPS)
  • Perioperative blood loss
  • Need for blood tranfusion

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

N.M.C. Mathijssen

Scientific

Reinier Haga Groep Orthopedisch Centrum B.V.

研究点 (1)

Loading locations...

相似试验